HDL cholesterol and apolipoprotein A-I: protective or paradoxical in glaucoma?

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/hdl-cholesterol-and-apolipoprotein-a-i-protective-or-paradoxical-in-glaucoma

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

HDL Cholesterol, ApoA-I and Glaucoma – Friend or Foe?Glaucoma – a leading cause of vision loss – is influenced not only by eye pressure but also by blood flow and inflammation in the eye. Some researchers are asking whether HDL cholesterol (often called “good cholesterol”) and its main protein component, apolipoprotein A-I (ApoA-I), help protect the optic nerve, or if under certain conditions they work in a paradoxical way. In general health, HDL carries cholesterol from tissues back to the liver and has anti-inflammatory and antioxidant actions. For example, HDL stimulates blood vessel cells to make nitric oxide (NO), a molecule that relaxes vessels and improves blood flow (). HDL particles also carry enzymes like paraoxonase-1 (PON1) that break down harmful oxidized fats. In fact, research in eye disease notes that low PON1 activity (and thus dysfunctional HDL) has been seen in glaucoma patients (). ApoA-I, the main protein on HDL, itself has strong anti-inflammatory effects: its levels drop sharply during acute inflammation, and it can suppress key inflammatory signals like TNF-α and IL-1 (). In short, under healthy conditions, HDL and ApoA-I tend to support blood vessel health and tame inflammation – which should, in theory, help keep the tiny retinal and optic nerve blood vessels open.The “HDL Paradox” in Chronic DiseaseHowever, the story gets more complex in chronic diseases. Studies have found that in persistently inflamed states (like arthritis, diabetes, or heart disease), HDL can become “dysfunctional” (). Instead of protecting vessels, it may carry abnormal proteins or lose its beneficial enzymes. One review notes that during atherosclerosis or chronic inflammation, HDL can even take on pro-inflammatory properties (). In rheumatic diseases, a so-called “lipid paradox” is seen: patients often have low cholesterol but higher heart risk, because inflammation both lowers HDL levels and makes the remaining HDL work poorly (). Even in the general population, valuing very high HDL can be misleading. A large Copenhagen study found that people with extremely high HDL had higher mortality, resulting in a U-shaped risk curve () (). In other words, too much HDL was paradoxically linked to worse outcomes. This does not mean HDL is bad per se, but it highlights that the simple HDL cholesterol number does not always capture its true function. HDL, ApoA-I and Eye Blood FlowHow might this apply to the eye? Glaucoma involves loss of retinal nerve cells and optic nerve damage. Good optic nerve health likely depends on steady blood supply. Optical Coherence Tomography Angiography (OCTA) is a scan that lets doctors see tiny blood vessels in the eye. Studies show that glaucoma patients often have reduced vessel density on OCTA – especially around the optic nerve and macula – and worse visual field if blood flow is poorer. For example, one study found that each 1% drop in optic nerve head capillary density on OCTA doubled the risk of glaucoma visual field worsening (). In other words, better ocular perfusion (blood flow) appears to slow disease progression.Given HDL’s role in healthy vessels, we might expect higher HDL or ApoA-I to support ocular perfusion. Indeed, some groups have found higher HDL or ApoA-I is linked